Learn More
Apexbio Technology LLC Clindamycin palmitate HCl 25507-04-4 50mg

Supplier: Apexbio Technology LLC B191450
Clindamycin palmitate HCl is a lincosamide antibiotic derivative that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit resulting in bacteriostatic activity In in vitro studies Clindamycin palmitate HCl demonstrates inhibitory effects against Gram-positive bacteria and anaerobes Based on these pharmacological properties Clindamycin palmitate HCl holds research potential in evaluating antibacterial effects investigating bacterial resistance mechanisms and exploring therapeutic efficacy in infectious disease models as well as serving in studies of metabolic pathways and drug delivery related to clindamycin derivatives
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.